Literature DB >> 19167443

Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia.

Vesna Boraska1, Eleftheria Zeggini, Christopher J Groves, Nigel W Rayner, Veselin Skrabić, Mahamadou Diakite, Kirk A Rockett, Dominic Kwiatkowski, Mark I McCarthy, Tatijana Zemunik.   

Abstract

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) are cytokines with a wide range of inflammatory and immunomodulatory activities. Type 1 diabetes is an autoimmune disease characterized by destruction of insulin-producing pancreatic beta cells. The aim of the present study was to evaluate the association of polymorphisms in the TNF/LTA gene region with susceptibility to type 1 diabetes. We investigated 11 TNF/LTA tag polymorphisms, designed to capture the majority of common variation in the region, in 160 trio families from South Croatia. We observed overtransmission of alleles from parents to affected child at five variants: (rs909253, allele C, p = 1.2x10(-4); rs1041981, allele A, p = 1.1x10(-4); rs1800629 (G-308A), allele A, p = 1.2x10(-4); rs361525 (G-238A), allele G, p = 8.2x10(-3) and rs3093668, allele G, p = 0.014). We also identified overtransmission of the rs1800629(G-308A)-rs361525(G-238A) A-G haplotype, p = 2.384x10(-5). The present study found an association of the TNF/LTA gene region with type 1 diabetes. A careful assessment of TNF/LTA variants adjusted for linkage disequilibrium with HLA loci is needed to further clarify the role of these genes in type 1 diabetes susceptibility in the population of South Croatia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167443      PMCID: PMC2709221          DOI: 10.1016/j.humimm.2008.12.010

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  39 in total

1.  In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading.

Authors:  Julian C Knight; Brendan J Keating; Kirk A Rockett; Dominic P Kwiatkowski
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

2.  Candidate gene association analysis for a quantitative trait, using parent-offspring trios.

Authors:  W James Gauderman
Journal:  Genet Epidemiol       Date:  2003-12       Impact factor: 2.135

3.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

4.  Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese.

Authors:  K Hamaguchi; A Kimura; N Seki; T Higuchi; S Yasunaga; M Takahashi; T Sasazuki; Y Kusuda; T Okeda; K Itoh; T Sakata
Journal:  Tissue Antigens       Date:  2000-01

5.  Association between G-308A polymorphism of the tumor necrosis factor-alpha gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents.

Authors:  D Krikovszky; B Vásárhelyi; P Tóth-Heyn; A Körner; T Tulassay; L Madácsy
Journal:  Clin Genet       Date:  2002-12       Impact factor: 4.438

Review 6.  Apoptosis genes and autoimmunity.

Authors:  D L Vaux; R A Flavell
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

7.  IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.

Authors:  K-A Kim; S Kim; I Chang; G S Kim; Y-K Min; M-K Lee; K-W Kim; M-S Lee
Journal:  Diabetologia       Date:  2002-03       Impact factor: 10.122

8.  TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population.

Authors:  L Bouqbis; O Akhayat; H-J Garchon; F Calafell; H Izaabel
Journal:  Tissue Antigens       Date:  2003-01

9.  Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients.

Authors:  Mouna Stayoussef; Fayza A Al-Jenaidi; Abduljabbar Al-Abbasi; Khadija Al-Ola; Haya Khayyat; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

10.  TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes.

Authors:  Masataka Nishimura; Hiroshi Obayashi; Ikuko Mizuta; Hirokazu Hara; Tetsuo Adachi; Mitsuhiro Ohta; Hisataka Tegoshi; Michiaki Fukui; Goji Hasegawa; Hirofumi Shigeta; Yoshihiro Kitagawa; Koji Nakano; Ryuji Kaji; Naoto Nakamura
Journal:  Hum Immunol       Date:  2003-02       Impact factor: 2.850

View more
  6 in total

Review 1.  Leprosy as a genetic disease.

Authors:  Andrea Alter; Audrey Grant; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Mamm Genome       Date:  2010-10-09       Impact factor: 2.957

2.  Associations between TNF gene polymorphisms (-308 A/G, -238 A/G, -1031 C/T and -857 T/C) and genetic susceptibility to T1D: a meta-analysis.

Authors:  Peng-Fei Wen; Xiao-Song Wang; Min Zhang; Han Cen; Hai-Feng Pan; Qian-Ling Ye; Chen Mao; Dong-Qing Ye
Journal:  Endocrine       Date:  2014-02-11       Impact factor: 3.633

3.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

4.  TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients.

Authors:  Hannan Al-Rayes; Ramiz Al-Swailem; Maysson Albelawi; Misbahul Arfin; Abdulrahman Al-Asmari; Mohammad Tariq
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2011-06-14

5.  Tumour necrosis factor gene polymorphisms in Egyptian patients with rheumatoid arthritis and their relation to disease activity and severity.

Authors:  Heba M Zaghlol; Sanaa Abdelshafy; Rabab A Mohamed; Enas A Abdelaleem
Journal:  Cent Eur J Immunol       Date:  2019-09-30       Impact factor: 2.085

6.  Inflammation-related cytokine gene polymorphisms in Behçet's disease.

Authors:  Fahda Al-Okaily; Misbahul Arfin; Seham Al-Rashidi; Maysoon Al-Balawi; Abdulrahman Al-Asmari
Journal:  J Inflamm Res       Date:  2015-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.